Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening

ConditionHPV

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorM.D. Anderson Cancer Center

About this trial

Cervical cancer is a disease that is preventable through vaccination against the virus that causes it, human papillomavirus (HPV), and through screening and treatment of cervical disease before it becomes cancet.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Provision of signed and dated informed consent form

Currently resident in RGV or other low-resource community in Texas

Stated willingness to comply with all study procedures

Females; Age ≥25 years

Disqualifiers

Unable to communicate in English or Spanish

Lack valid telephone contact information

Report being currently pregnant.

Trial design

Design model

Single group

Treatments tested in this trial

PRECEDE-PROCEED
Behavioral
delivered self-sampling (CHWSS) to increase screening participation.

Treatment groups

920 Participants

are divided into 1 treatment group

Group A: PRECEDE-PROCEEDExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Time frame

through study completion; an average 1 year.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

M.D. Anderson Cancer Center

Lead sponsor

Source ClinicalTrials.gov

Apply now